TY - JOUR
T1 - Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis
AU - Ben-Assa, Eyal
AU - Brown, Jonathan
AU - Keshavarz-Motamed, Zahra
AU - De La Torre Hernandez, Jose M.
AU - Leiden, Benjamin
AU - Olender, Max
AU - Kallel, Faouzi
AU - Palacios, Igor F.
AU - Inglessis, Ignacio
AU - Passeri, Jonathan J.
AU - Shah, Pinak B.
AU - Elmariah, Sammy
AU - Leon, Martin B.
AU - Edelman, Elazer R.
N1 - Publisher Copyright:
Copyright © 2019 The Authors.
PY - 2019/9/11
Y1 - 2019/9/11
N2 - Aortic stenosis (AS) management is classically guided by symptoms and valvular metrics. However, the natural history of AS is dictated by coupling of the left ventricle, aortic valve, and vascular system. We investigated whether metrics of ventricular and vascular state add to the appreciation of AS state above valve gradient alone. Seventy patients with severe symptomatic AS were prospectively followed from baseline to 30 days after transcatheter aortic valve replacement (TAVR). Quality of life (QOL) was assessed using the Kansas City Cardiomyopathy Questionnaire. Left ventricular stroke work (SWLV) and vascular impedance spectrums were calculated noninvasively using in-house models based on central blood pressure waveforms, along with hemodynamic parameters from echocardiograms. Patients with higher preprocedural SWLV and lower vascular impedance were more likely to experience improved QOL after TAVR. Patients fell into two categories: those who did and those who did not exhibit increase in blood pressure after TAVR. In patients who developed hypertension (19%), vascular impedance increased and SWLV remained unchanged (impedance at zeroth harmonic: Z0, from 3964.4 to 4851.8 dynes/cm3, P = 0.039; characteristic impedance: Zc, from 376.2 to 603.2 dyne s/cm3, P = 0.033). SWLV dropped only in patients who did not develop new hypertension after TAVR (from 1.58 to 1.26 J; P < 0.001). Reduction in valvular pressure gradient after TAVR did not predict change in SWLV (r = 0.213; P = 0.129). Reduction of SWLV after TAVR may be an important metric in management of AS, rather than relying solely on the elimination of transvalvular pressure gradients.
AB - Aortic stenosis (AS) management is classically guided by symptoms and valvular metrics. However, the natural history of AS is dictated by coupling of the left ventricle, aortic valve, and vascular system. We investigated whether metrics of ventricular and vascular state add to the appreciation of AS state above valve gradient alone. Seventy patients with severe symptomatic AS were prospectively followed from baseline to 30 days after transcatheter aortic valve replacement (TAVR). Quality of life (QOL) was assessed using the Kansas City Cardiomyopathy Questionnaire. Left ventricular stroke work (SWLV) and vascular impedance spectrums were calculated noninvasively using in-house models based on central blood pressure waveforms, along with hemodynamic parameters from echocardiograms. Patients with higher preprocedural SWLV and lower vascular impedance were more likely to experience improved QOL after TAVR. Patients fell into two categories: those who did and those who did not exhibit increase in blood pressure after TAVR. In patients who developed hypertension (19%), vascular impedance increased and SWLV remained unchanged (impedance at zeroth harmonic: Z0, from 3964.4 to 4851.8 dynes/cm3, P = 0.039; characteristic impedance: Zc, from 376.2 to 603.2 dyne s/cm3, P = 0.033). SWLV dropped only in patients who did not develop new hypertension after TAVR (from 1.58 to 1.26 J; P < 0.001). Reduction in valvular pressure gradient after TAVR did not predict change in SWLV (r = 0.213; P = 0.129). Reduction of SWLV after TAVR may be an important metric in management of AS, rather than relying solely on the elimination of transvalvular pressure gradients.
UR - https://www.scopus.com/pages/publications/85072132061
U2 - 10.1126/scitranslmed.aaw0181
DO - 10.1126/scitranslmed.aaw0181
M3 - Article
C2 - 31511424
AN - SCOPUS:85072132061
SN - 1946-6234
VL - 11
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 509
M1 - eaaw0181
ER -